IMARC Group, a leading market research company, has recently releases report titled “Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global facial injectables market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the facial injectables market?

The global facial injectables market size reached US$ 7.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 9.64% during 2023-2028.

What are facial injectables?

Facial injectables, or derma fillers, are gel-like synthetic or naturally occurring substances injected in the folds, lines, and tissues of the face for cosmetic and therapeutic procedures. They are used for enhancing facial contours, plumping cheeks and lips, correcting acne scars and minimizing the visibility of smile lines. Some commonly used facial injectables include collagen, hyaluronic acid and calcium hydroxyl fillers. In comparison to plastic surgeries, they are usually absorbable and can be altered to provide permanent or temporary results based on the requirement of the consumer.

Request for a sample copy of this report: https://www.imarcgroup.com/facial-injectables-market/requestsample

What are the growth prospects and trends in the facial injectables industry?

The global facial injectables market is primarily driven by the increasing consciousness among the masses regarding physical appearance and the rising preference for minimally invasive (MI) cosmetic procedures. Moreover, the widespread adoption of hyaluronic acid as a natural filler to maintain healthy moisture levels and reverse skin damage is providing a thrust to the market growth. Product manufacturers are also developing innovative wrinkle relaxers and fillers with lower risks of infections, minimal blood loss and lesser recovery time. Other factors, including the rising geriatric population and increasing expenditure capacities of the consumers, are anticipated to drive the market toward growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Polymethylmethacrylate Beads (PMMA Microspheres)
  • Poly-L-Lactic Acid (PLLA)
  • Others

Breakup by Application Type:

  • Aesthetics
  • Therapeutics

Breakup by Application:

  • Facial Line Correction
  • Lip Augmentation
  • Face Lift
  • Acne Scar Treatment
  • Others

Breakup by End User:

  • Hospitals
  • Dermatology Clinics
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Allergan Plc
  • Anika Therapeutics Inc.
  • Bloomage BioTechnology
  • Johnson & Johnson
  • Galderma Pharma S.A.
  • Integra LifeSciences
  • Ipsen (Mayroy SA)
  • Medytox Inc.
  • Merz Holding GmbH & Co. KG
  • Prollenium Medical Technologies Inc.
  • Sanofi
  • SciVision Biotech Inc.
  • Sinclair Pharma (Huadong Medicine Co. Ltd.)
  • Suneva Medical Inc.
  • Bausch Health Companies Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal